Branded Generics Market Size & Share | Industry Analysis 2028

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Branded Generics Market – By Therapeutic Application

1.3.2 Global Branded Generics Market – By Distribution Channel

1.3.3 Global Branded Generics Market – By Drug Class

1.3.4 Global Branded Generics Market – By Formulation Type

1.3.5 Global Branded Generics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Branded Generics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Branded Generics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Penetration of Branded Generics

5.1.2 Increasing Government Initiatives for Promoting Branded Generics

5.2 Market Restraints

5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications

5.3 Market Opportunities

5.3.1 Product Differentiation

5.4 Future Trends

5.4.1 Encouraging Utility of Branded Generics by Healthcare Providers and Professionals

5.5 Impact Analysis

6. Branded Generics Market– Global Analysis

6.1 Global Branded Generics Market Revenue Forecast and Analysis

6.2 Global Branded Generics Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

6.4 Global Branded Generics Market – Market Potential Analysis, By Region

6.5 Comparative Company Analysis

6.6 Growth Strategy Analysis

6.7 Performance of Key Players

6.7.1.1 Teva Pharmaceuticals Industries Ltd.

6.7.1.2 Sandoz International GmbH

6.8 Market Share Analysis of Branded Generics Market

7. Global Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application

7.1 Overview

7.2 By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)

7.3 Oncology

7.3.1 Overview

7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)

7.4 Cardiovascular Diseases

7.4.1 Overview

7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.5 Diabetes

7.5.1 Overview

7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

7.6 Neurology

7.6.1 Overview

7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)

7.7 Gastrointestinal Diseases

7.7.1 Overview

7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.8 Dermatology Diseases

7.8.1 Overview

7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.9 Analgesics and Anti-Inflammatory

7.9.1 Overview

7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

7.10 Others

7.10.1 Overview

7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)

8. Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel

8.1 Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

8.2 Hospital Pharmacies

8.2.1 Overview

8.2.2 Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.3 Retail Pharmacies

8.3.1 Overview

8.3.2 Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.4 Online Pharmacies

8.4.1 Overview

8.4.2 Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.5 Drug Stores

8.5.1 Overview

8.5.2 Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9. Branded Generics Market Analysis and Forecast to 2028 by Drug Class

9.1 Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

9.2 Alkylating Agents

9.2.1 Overview

9.2.2 Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.3 Antimetabolites

9.3.1 Overview

9.3.2 Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.4 Hormones

9.4.1 Overview

9.4.2 Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.5 Anti-hypertensive

9.5.1 Overview

9.5.2 Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.6 Lipid Lowering Drugs

9.6.1 Overview

9.6.2 Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.7 Anti-Depressants

9.7.1 Overview

9.7.2 Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.8 Anti-psychotics

9.8.1 Overview

9.8.2 Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.9 Anti-epileptic

9.9.1 Overview

9.9.2 Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.10 Others

9.10.1 Overview

9.10.2 Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10. Global Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type

10.1 Overview

10.2 Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

10.3 Oral

10.3.1 Overview

10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)

10.4 Parenteral

10.4.1 Overview

10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

10.5 Topical

10.5.1 Overview

10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)

10.6 Others

10.6.1 Overview

10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)

11. Branded Generics Market Revenue and Forecasts to 2028 Geographical Analysis

11.1 North America: Branded Generics Market

11.1.1 Overview

11.1.2 North America: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.3 North America: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.4 North America: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.5 North America: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.6 North America: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.7 North America: Branded Generics Market, by Country, 2022 & 2028 (%)

11.1.7.1 US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.1.1 Overview

11.1.7.1.2 US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.1.3 US: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.7.1.4 US: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.7.1.5 US: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.7.1.6 US: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.7.2 Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.2.1 Overview

11.1.7.2.2 Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.2.3 Canada: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.7.2.4 Canada: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.7.2.5 Canada: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.7.2.6 Canada: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.7.3 Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.3.1 Overview

11.1.7.3.2 Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.3.3 Mexico: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.7.3.4 Mexico: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.7.3.5 Mexico: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.7.3.6 Mexico: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.2 Europe: Branded Generics Market

11.2.1 Overview

11.2.2 Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.3 Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.4 Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.5 Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.6 Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7 Europe: Branded Generics Market, by Country, 2022 & 2028 (%)

11.2.7.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.2 Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.3 Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.4 Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.5 Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.1 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.2 France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.3 France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.4 France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.5 France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.1 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.2 UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.3 UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.4 UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.5 UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.1 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.2 Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.3 Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.4 Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.5 Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.1 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.2 Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.3 Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.4 Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.5 Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.1 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.2 Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.3 Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.4 Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.5 Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.3 Asia Pacific Branded Generics Market Revenue and Forecasts To 2028

11.3.1 Overview

11.3.2 Asia Pacific Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.3 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.4 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.5 Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.6 Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

11.3.7.1 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.1.1 Overview

11.3.7.1.2 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.1.3 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.1.4 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.1.5 Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.1.6 Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.2.1 Overview

11.3.7.2.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.2.3 China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.2.4 China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.2.5 China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.2.6 China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.3 India Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.3.1 Overview

11.3.7.3.2 India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.3.3 India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.3.4 India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.3.5 India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.3.6 India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.4.1 Overview

11.3.7.4.2 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.4.3 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.4.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.4.5 South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.4.6 South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.5 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.5.1 Overview

11.3.7.5.2 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.5.3 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.5.4 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.5.5 Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.5.6 Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6 Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6.1 Overview

11.3.7.6.2 Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6.3 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.6.4 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.6.5 Rest of Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6.6 Rest of Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.4 Middle East & Africa: Branded Generics Market Revenue and Forecast To 2028

11.4.1 Overview

11.4.2 Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.3 Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.4 Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.5 Middle East & Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.6 Middle East & Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7 Middle East & Africa: Branded Generics Market, by Country, 2022 & 2028 (%)

11.4.7.1 UAE: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.1.1 Overview

11.4.7.1.2 UAE: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.1.3 UAE: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.1.4 UAE: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.1.5 UAE: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.1.6 UAE: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7.2 Saudi Arabia: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.2.1 Overview

11.4.7.2.2 Saudi Arabia: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.2.3 Saudi Arabia: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.2.4 Saudi Arabia: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.2.5 Saudi Arabia: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.2.6 Saudi Arabia: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7.3 South Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.3.1 Overview

11.4.7.3.2 South Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.3.3 South Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.3.4 South Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.3.5 South Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.3.6 South Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7.4 Rest of Middle the East and Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.4.1 Overview

11.4.7.4.2 Rest of Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.4.3 Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.4.4 Rest of Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.4.5 Rest of Middle East & Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.4.6 Rest of Middle East & Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.5 South and Central America Branded Generics Market Revenue and Forecast to 2028

11.5.1 Overview

11.5.2 South & Central America Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.3 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.4 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.5 South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.6 South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.5.7 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

11.5.7.1 Argentina Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.5.7.1.1 Overview

11.5.7.1.2 Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.7.1.3 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.7.1.4 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.7.1.5 Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.7.1.6 Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.5.7.2 Brazil: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.5.7.2.1 Overview

11.5.7.2.2 Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.7.2.3 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.7.2.4 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.7.2.5 Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.7.2.6 Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.5.7.3 Rest of South and Central America: Branded Generics Market– Revenue and Forecast to 2028 (USD Billion)

11.5.7.3.1 Overview

11.5.7.3.2 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.7.3.3 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.7.3.4 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.7.3.5 Rest of South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.7.3.6 Rest of South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

12. Impact Of COVID-19 Pandemic on Branded Generics Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12.5 SAM: Impact Assessment of COVID-19 Pandemic

13. Branded Generics Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 MYLAN N.V.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 TEVA PHARMACEUTICAL INDUSTRIES LTD

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GlaxoSmithKline plc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Bausch Health Companies Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Lupin

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Sanofi

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 ASTRAZENECA PLC.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Dr. Reddy's Laboratories

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Par Pharmaceuticals, INC

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Sandoz International GMBH

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Aspen Holdings

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Hetero

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 2. North America Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Billion)

Table 3. North America Branded Generics Market, by Drug Class– Revenue and Forecast to 2028 (US$ Billion)

Table 4. North America Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 5. US Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 6. US Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 7. US Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 8. US Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 9. Canada: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 10. Canada Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 11. Canada Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 12. Canada Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 13. Mexico: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 14. Mexico Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 15. Mexico Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 16. Mexico Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 17. Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 18. Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 19. Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 20. Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 21. Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 22. Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 23. Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 24. Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 25. France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 26. France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 27. France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 28. France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 29. UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 30. UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 31. UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 32. UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 33. Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 34. Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 35. Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 36. Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 37. Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 38. Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 39. Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 40. Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 41. Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 42. Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 43. Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 44. Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 45. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).

Table 46. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 47. Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 48. Asia Pacific: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 49. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 50. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 51. Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 52. Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 53. China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 54. China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 55. China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 56. China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 57. India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 58. India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 59. India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 60. India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 61. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 62. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 63. South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 64. South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 65. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 66. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 67. Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 68. Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 69. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 70. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 71. Rest of Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 72. Rest of Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 73. Middle East & Africa Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 74. Middle East & Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Billion)

Table 75. Middle East & Africa Branded Generics Market, by Drug Class– Revenue and Forecast to 2028 (US$ Billion)

Table 76. Middle East & Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 77. UAE Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 78. UAE Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 79. UAE Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 80. UAE Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 81. Saudi Arabia: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 82. Saudi Arabia Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 83. Saudi Arabia Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 84. Saudi Arabia Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 85. South Africa: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 86. South Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 87. South Africa Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 88. South Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 89. Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 90. Rest of Middle East & Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 91. Rest of Middle East & Africa Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 92. Rest of Middle East & Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 93. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).

Table 94. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 95. South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 96. South & Central America: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 97. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 98. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 99. Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 100. Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 101. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 102. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 103. Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 104. Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 105. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 106. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 107. Rest of South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 108. Rest of South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 109. Organic Developments Done By Companies

Table 110. Inorganic Developments Done By Companies

Table 111. Glossary of Terms

LIST OF FIGURES

Figure 1. Branded Generics Market Segmentation

Figure 2. Branded Generics Market, By Region

Figure 3. Global Branded Generics Market Overview

Figure 4. Others Segment Held Largest Share of Drug Class Segment in Branded Generics Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Branded Generics Market, by Geography (US$ Million)

Figure 7. Global Branded Generics Market - Leading Country Markets (US$ Billion)

Figure 8. Global Branded Generics Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East And Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Impact Analysis of Drivers and Restraints on Branded Generics Market

Figure 16. Global Branded Generics Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 17. Global Branded Generics Market – By Geography Forecast and Analysis – 2022 - 2028

Figure 18. Market Positioning of Key Players in Branded Generics Market

Figure 19. Global Branded Generics Market – Market Potential Analysis, By Region

Figure 20. Global Branded Generics Market – Comparative Company Analysis

Figure 21. Global Branded Generics Market – Growth Strategy Analysis

Figure 22. Market Share Analysis of Key Players in Global Branded Generics Market

Figure 23. By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)

Figure 24. Oncology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 25. Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 26. Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

Figure 27. Neurology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 28. Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 29. Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 30. Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

Figure 31. Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 32. Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

Figure 33. Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 34. Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 35. Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 36. Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 37. Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

Figure 38. Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 39. Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 40. Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 41. Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 42. Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 43. Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 44. Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 45. Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 46. Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 47. Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

Figure 48. Oral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 49. Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 50. Topical Market Revenue and Forecast to 2028 (US$ Billion)

Figure 51. Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 52. North America: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)

Figure 53. North America Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

Figure 54. North America: Branded Generics Market, by Country, 2022 & 2028 (%)

Figure 55. US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 56. Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 57. Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 58. Europe: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)

Figure 59. Europe: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

Figure 60. Europe: Branded Generics Market, by Country, 2022 & 2028 (%)

Figure 61. Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 62. France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 63. UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 64. Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 65. Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 66. Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 67. Asia Pacific Branded Generics Market Overview, by Country (2022)

Figure 68. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 69. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

Figure 70. Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 71. China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 72. India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 73. South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 74. Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 75. Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 76. Middle East & Africa: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)

Figure 77. Middle East & Africa Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

Figure 78. Middle East & Africa: Branded Generics Market, by Country, 2022 & 2028 (%)

Figure 79. UAE: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 80. SAudi Arabia: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 81. South Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 82. Rest of Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 83. South & Central America Branded Generics Market Overview, by Country (2022)

Figure 84. South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 85. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

Figure 86. Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 87. Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 88. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 89. Impact of COVID-19 Pandemic in North American Country Markets

Figure 90. Impact of COVID-19 Pandemic in European Country Markets

Figure 91. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 92. Impact of COVID-19 Pandemic in Middle East & African Country Markets

Figure 93. Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 94. Growth Strategies Done by the Companies in the Market (%)